These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15025182)

  • 1. Effect of Pluronic on cellular uptake of cationic liposomes- mediated antisense oligonucleotides.
    Chen HL; Hu QH; Liang WQ
    Pharmazie; 2004 Feb; 59(2):131-3. PubMed ID: 15025182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preparation of cationic liposomes and its role in enhancing cellular uptake of antisense oligonucleotides].
    Chen HL; Liang WQ; Shao JB; Chen Z
    Yao Xue Xue Bao; 2004 Jan; 39(1):72-6. PubMed ID: 15127587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo tumor suppressive activity induced by human telomerase transcriptase-targeting antisense oligonucleotides mediated by cationic liposomes.
    Han M; Chen JL; Hu Y; He CL; Shuai WP; Yu JH; Chen HL; Liang WQ; Mayumi T; Shinsaku N; Gao JQ
    J Biosci Bioeng; 2008 Sep; 106(3):243-7. PubMed ID: 18929999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cationic liposome (DC-Chol/DOPE=1:2) and a modified ethanol injection method to prepare liposomes, increased gene expression.
    Maitani Y; Igarashi S; Sato M; Hattori Y
    Int J Pharm; 2007 Sep; 342(1-2):33-9. PubMed ID: 17566677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anionic amino acid-derived cationic lipid for siRNA delivery.
    Suh MS; Shim G; Lee HY; Han SE; Yu YH; Choi Y; Kim K; Kwon IC; Weon KY; Kim YB; Oh YK
    J Control Release; 2009 Dec; 140(3):268-76. PubMed ID: 19567256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cationic liposomes loaded with doxorubicin targeting to the tumor neovasculature in vitro].
    Zhao W; Ma HL; Qi XR
    Yao Xue Xue Bao; 2007 Sep; 42(9):982-8. PubMed ID: 18050743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The characterization of cationic fusogenic liposomes mediated antisense oligonucleotides into HeLa cells.
    Hu Y; Jin Y; Xia Y
    Drug Dev Ind Pharm; 2004 Feb; 30(2):135-41. PubMed ID: 15089047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on the characteristics of antisense oligodeoxy-neucleotides-liposomes complex and cellular uptake].
    Chen HL; Chen Z; Liang WQ
    Yao Xue Xue Bao; 2002 Sep; 37(9):728-32. PubMed ID: 12567901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient delivery of an antisense oligodeoxyribonucleotide formulated in folate receptor-targeted liposomes.
    Chiu SJ; Marcucci G; Lee RJ
    Anticancer Res; 2006; 26(2A):1049-56. PubMed ID: 16619505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel cationic liposome formulation for the delivery of an oligonucleotide decoy to NF-kappaB into activated macrophages.
    De Rosa G; De Stefano D; Laguardia V; Arpicco S; Simeon V; Carnuccio R; Fattal E
    Eur J Pharm Biopharm; 2008 Sep; 70(1):7-18. PubMed ID: 18482831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cationic liposomes modified with non-ionic surfactants as effective non-viral carrier for gene transfer.
    Huang YZ; Gao JQ; Chen JL; Liang WQ
    Colloids Surf B Biointerfaces; 2006 May; 49(2):158-64. PubMed ID: 16626948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved formulations of antisense oligodeoxynucleotides using wrapped liposomes.
    Yamauchi M; Kusano H; Saito E; Iwata T; Nakakura M; Kato Y; Uochi T; Akinaga S; Aoki N
    J Control Release; 2006 Aug; 114(2):268-75. PubMed ID: 16860428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An antisense oligonucleotide carrier based on amino silica nanoparticles for antisense inhibition of cancer cells.
    Peng J; He X; Wang K; Tan W; Li H; Xing X; Wang Y
    Nanomedicine; 2006 Jun; 2(2):113-20. PubMed ID: 17292123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes.
    Ramezani M; Khoshhamdam M; Dehshahri A; Malaekeh-Nikouei B
    Colloids Surf B Biointerfaces; 2009 Aug; 72(1):1-5. PubMed ID: 19395245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folate-mediated chondroitin sulfate-Pluronic 127 nanogels as a drug carrier.
    Huang SJ; Sun SL; Feng TH; Sung KH; Lui WL; Wang LF
    Eur J Pharm Sci; 2009 Aug; 38(1):64-73. PubMed ID: 19540339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(L-lysine)-modified silica nanoparticles for the delivery of antisense oligonucleotides.
    Zhu SG; Xiang JJ; Li XL; Shen SR; Lu HB; Zhou J; Xiong W; Zhang BC; Nie XM; Zhou M; Tang K; Li GY
    Biotechnol Appl Biochem; 2004 Apr; 39(Pt 2):179-87. PubMed ID: 15032738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of antisense oligonucleotides using cholesterol-modified sense dendrimers and cationic lipids.
    Chaltin P; Margineanu A; Marchand D; Van Aerschot A; Rozenski J; De Schryver F; Herrmann A; Müllen K; Juliano R; Fisher MH; Kang H; De Feyter S; Herdewijn P
    Bioconjug Chem; 2005; 16(4):827-36. PubMed ID: 16029024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biosurfactant MEL-A enhances cellular association and gene transfection by cationic liposome.
    Igarashi S; Hattori Y; Maitani Y
    J Control Release; 2006 May; 112(3):362-8. PubMed ID: 16624437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the biological activity of anti-ICAM-1 oligonucleotides complexed to non-viral carriers.
    Lucas B; Van Rompaey E; Remaut K; Sanders N; De Smedt SC; Demeester J
    J Control Release; 2004 Apr; 96(1):207-19. PubMed ID: 15063042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-assembled silk sericin/poloxamer nanoparticles as nanocarriers of hydrophobic and hydrophilic drugs for targeted delivery.
    Mandal BB; Kundu SC
    Nanotechnology; 2009 Sep; 20(35):355101. PubMed ID: 19671963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.